1.94
-0.02 (-1.02%)
-0.02 (-1.02%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Hepion Pharmaceuticals Inc | HEPA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.02 | -1.02% | 1.94 | 19:59:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.95 | 1.83 | 2.0099 | 1.88 | 1.96 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.93 | 1.94 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 17,957 | 7,812,992 | $ 1.91 | $ 14,928,256 | 2,786,818 | 1.00 - 6.18 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:54 | formt | 416 | $ 1.94 | USD |
Hepion Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 62.13M | 32.03M | 32.02M | $ - | $ - | -15.29 | -1.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Hepion Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HEPA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.325 | 2.41 | 1.83 | 2.18 | 14,164,539 | -0.385 | -16.56% |
| 1 Month | 2.08 | 3.18 | 1.83 | 2.26 | 10,292,811 | -0.14 | -6.73% |
| 3 Months | 1.59 | 3.18 | 1.54 | 2.17 | 5,201,383 | 0.35 | 22.01% |
| 6 Months | 3.54 | 4.24 | 1.51 | 2.17 | 2,608,762 | -1.60 | -45.2% |
| 1 Year | 4.41 | 6.18 | 1.00 | 2.50 | 1,897,867 | -2.47 | -56.01% |
| 3 Years | 3.11 | 8.35 | 1.00 | 2.95 | 1,551,911 | -1.17 | -37.62% |
| 5 Years | 3.11 | 8.35 | 1.00 | 2.95 | 1,551,911 | -1.17 | -37.62% |
Hepion Pharmaceuticals Description
| Hepion Pharmaceuticals Inc is a United States-based biopharmaceutical company engaged in the development of targeted pharmaceutical therapies for liver disease. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. The company's cyclophilin inhibitor, CRV431 targets multiple biochemical pathways involved in the progression of liver disease. |
